LAVA Therapeutics NV SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE15-12GLAVA Therapeutics NVLVTXDec 16, 2025

   Deregistration notice

2. ROUTINE25-NSE/ALAVA Therapeutics NVLVTXNov 21, 2025

   Nasdaq Stock Market LLC filed 25-NSE/A

   • Form Type: 25-NSE/A
   • Filing Date: 2025-11-21

   Nasdaq Stock Market LLC, filed by

3. ROUTINES-8 POSLAVA Therapeutics NVLVTXNov 21, 2025

   LAVA Therapeutics NV filed S-8 POS

   • Form Type: S-8 POS
   • Filing Date: 2025-11-21
4. ROUTINES-8 POSLAVA Therapeutics NVLVTXNov 21, 2025

   LAVA Therapeutics NV filed S-8 POS

   • Form Type: S-8 POS
   • Filing Date: 2025-11-21
5. ROUTINESC 14D9/ALAVA Therapeutics NVLVTXNov 21, 2025

   LAVA Therapeutics NV filed SC 14D9/A

   • Form Type: SC 14D9/A
   • Filing Date: 2025-11-21
6. MAJOR8-KLAVA Therapeutics NVLVTXNov 21, 2025

   LAVA Therapeutics NV filed 8-K current report

   • Item 2.01
   • Item 3.01
   • Item 3.03
7. ROUTINESC TO-T/ALAVA Therapeutics NVLVTXNov 21, 2025

   LAVA Therapeutics NV filed SC TO-T/A

   • Form Type: SC TO-T/A
   • Filing Date: 2025-11-21

   XOMA Royalty Corp, filed by

8. ROUTINESC 14D9/ALAVA Therapeutics NVLVTXNov 13, 2025

   Tender offer response (amended)

9. ROUTINE8-KLAVA Therapeutics NVLVTXNov 13, 2025

   Current report

10. ROUTINESC TO-T/ALAVA Therapeutics NVLVTXNov 13, 2025

    Tender offer (amended)

    XOMA Royalty Corp, filed by

11. ROUTINESC 14D9/ALAVA Therapeutics NVLVTXNov 10, 2025

    Tender offer response (amended)

12. ROUTINE8-KLAVA Therapeutics NVLVTXNov 7, 2025

    Current report

13. NOTABLE10-QLAVA Therapeutics NVLVTXNov 6, 2025

    Quarterly report

Older filings on EDGAR